Skip to content
My WebMD Sign In, Sign Up
Font Size
A
A
A

5 Genes Linked to Aggressive Prostate Cancer

Study Could Lead to Test That Determines Which Patients Need Aggressive Treatment

Reducing Overtreatment for Prostate Cancer

Patients who carried four or all five of the SNPs had a 50% higher risk of dying from their cancer than patients who had two or fewer of the SNP variants.

The next step is to confirm the findings in different groups of patients and to determine if these five SNPs or any of the other identified gene variants are useful for predicting death from prostate cancer, Stanford says.

The study was published online today and will appear in the September issue of Cancer Epidemiology, Biomarkers and Prevention.

Phelps says finding better tests to identify patients who will benefit from therapy is an important goal for reducing the harms from prostate cancer overtreatment, along with finding more effective targeted therapies that do not have life-altering side effects.

"There has been an explosion of research examining targeted cancer therapies, and while we haven't struck pay dirt in prostate cancer yet, I think it's just a matter of time," he says.

1 | 2

Today on WebMD

Prostate Cancer Overview
SLIDESHOW
what is your cancer risk
HEALTH CHECK
 
Prostate Exam
VIDEO
Prostate Nerve Transplant
VIDEO
 
cancer fighting foods
SLIDESHOW
15 Cancer Symptoms Men Ignore
FEATURE
 
Prostate Enlarged
VIDEO
Picture Of The Prostate
ANATOMY
 
Prostate Cancer Quiz
QUIZ
screening tests for men
SLIDESHOW
 
Prostate Cancer Symptoms
VIDEO
Vitamin D
SLIDESHOW